Announcement from Zhejiang Wecome Pharmaceutical: On May 23, 2024, the company received the inquiry letter for the annual report from the Growth Enterprise Market Company Management Department of the Shenzhen Stock Exchange, requiring a reply before June 6, 2024. Due to the need for further verification of some matters, the company requested an extension of the reply time to June 14, 2024. As the reply content still needs to be supplemented and improved, the company again requested an extension of the reply time to before June 21, 2024.
维康药业：再次延期回复年报问询函至2024年6月21日前
Zhejiang Wecome Pharmaceutical: again extended the reply to the annual report inquiry letter to June 21, 2024.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.